Keliximab
Keliximab is a monoclonal antibody designed for the treatment of autoimmune diseases. It is classified under the immunoglobulin G (IgG) class of antibodies and specifically targets the CD4 molecule found on the surface of certain T cells.
Mechanism of Action[edit]
Keliximab works by binding to the CD4 molecule on T cells. This binding inhibits the interaction between T cells and antigen-presenting cells, thereby reducing the immune response that leads to the symptoms of autoimmune diseases.
Clinical Trials[edit]
Keliximab has been tested in several clinical trials for its efficacy in treating autoimmune diseases such as rheumatoid arthritis and psoriasis. However, the results have been mixed, with some trials showing significant improvement in symptoms, while others showed no significant difference compared to placebo.
Side Effects[edit]
Like all drugs, Keliximab has potential side effects. These can include infection due to the suppression of the immune system, allergic reactions to the drug, and potential cardiovascular effects.
Future Research[edit]
While Keliximab has shown promise in treating autoimmune diseases, more research is needed to fully understand its potential benefits and risks. Future research may focus on optimizing the dosage and administration of the drug, as well as exploring its potential use in other autoimmune diseases.
See Also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
